HOTHHoth Therapeutics Inc
HOTH
Hoth Therapeutics Inc11,512
Mkt Cap
$12.54MVolume
260,726.0052W High
$2.1252W Low
$0.6554PE Ratio
-0.76HOTH Fundamentals
Price
$0.8583Prev Close
$0.8082Open
$0.8350D MA
$1.06Beta
1.03Avg. Volume
677,081.05EPS (Annual)
-$1.28P/B
1.49Rev/Employee
$0.00Hoth Therapeutics Addresses Market Rumor, Hoth Holds No Crypto Currency Assets
Hoth Therapeutics Addresses Market Rumor, Hoth Holds No Crypto Currency Assets Hoth Therapeutics Addresses Market Rumor, Hoth Holds No Crypto Currency Assets PR Newswire NEW YORK, Feb. 5, 2026 NEW...
PR Newswire·4d ago
Hoth Therapeutics Early Cancer Trial Succeeds With 100% Patient Response, Cuts Disease Severity By Half
Hoth Therapeutics reported interim trial results showing all patients improved by Week 6, with reduced disease severity, fewer side effects, and early lasting benefits in cancer patients on EGFR...
Benzinga·18d ago
Hoth Therapeutics Delivers 100% Clinical Response with ~50% Reduction in Disease Severity in Open-Label PK Cohort of EGFR-Treated Cancer Patients
Hoth Therapeutics Delivers 100% Clinical Response with ~50% Reduction in Disease Severity in Open-Label PK Cohort of EGFR-Treated Cancer Patients Hoth Therapeutics Delivers 100% Clinical Response...
PR Newswire·18d ago
Hoth Therapeutics Secures Major International Patent Milestone for HT-KIT Cancer Program, Strengthening Global Oncology IP Position
Hoth Therapeutics Secures Major International Patent Milestone for HT-KIT Cancer Program, Strengthening Global Oncology IP Position Hoth Therapeutics Secures Major International Patent Milestone for...
PR Newswire·19d ago
Hoth Therapeutics Reaches Key EU Regulatory Inflection Point Advancing HT-001 Oncology Trial Toward Multi-Country Site Activation
Hoth Therapeutics Reaches Key EU Regulatory Inflection Point Advancing HT-001 Oncology Trial Toward Multi-Country Site Activation Hoth Therapeutics Reaches Key EU Regulatory Inflection Point...
PR Newswire·25d ago
Hoth Therapeutics Files Two Provisional Patents To Build Oncology Dermatology Platform
(RTTNews) - Hoth Therapeutics (HOTH) has filed two U.S. provisional patent applications that expand its intellectual property portfolio and lay the foundation for a new oncology-focused dermatology...
Nasdaq News: Markets·1mo ago
Hoth Therapeutics Expands Oncology Pipeline with Dual Patent Filings Establishing Novel Oncology Dermatology IP Platform
Hoth Therapeutics Expands Oncology Pipeline with Dual Patent Filings Establishing Novel Oncology Dermatology IP Platform Hoth Therapeutics Expands Oncology Pipeline with Dual Patent Filings...
PR Newswire·1mo ago
Hoth Therapeutics to Present at Noble Capital Markets 21st Annual Emerging Growth Equity Conference, December 2-3, 2025
Hoth Therapeutics to Present at Noble Capital Markets 21st Annual Emerging Growth Equity Conference, December 2-3, 2025 Hoth Therapeutics to Present at Noble Capital Markets 21st Annual Emerging...
PR Newswire·2mo ago
Hoth Therapeutics Accepted Into NVIDIA Connect Program, Expanding Its AI and Accelerated Computing Capabilities
Hoth Therapeutics Accepted Into NVIDIA Connect Program, Expanding Its AI and Accelerated Computing Capabilities Hoth Therapeutics Accepted Into NVIDIA Connect Program, Expanding Its AI and...
PR Newswire·3mo ago
Hoth Therapeutics Launches VA-Backed Study of Novel GDNF Weight Loss Therapy Targeting Obesity and Fatty Liver Disease
Hoth Therapeutics Launches VA-Backed Study of Novel GDNF Weight Loss Therapy Targeting Obesity and Fatty Liver Disease Hoth Therapeutics Launches VA-Backed Study of Novel GDNF Weight Loss Therapy...
PR Newswire·4mo ago
<
1
2
...
>